Antineoplastic combinations
USRE41253E1 · kind E1 · reissue
2Cited by
32References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2007 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Oct 26, 2027 |
Classification
- Technology area (CPC —)General
Abstract
This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.